Rocaglaol TN5639
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Rocaglaol is a potent anticancer drug that induces apoptosis of LNCaP cells through the mitochondrial pathway and its G2/M-phase cell cycle arrest is associated with the down-regulation of Cdc25C and the dephosphorylation of Cdc2. Rocaglaol can reduce tis
CAS nr:
147059-46-9
Purity:
98%
Molecular Weight:
SMILES:
Formula:
C26H26O6
Pathway:
Target:
